TKNO
Alpha Teknova, Inc. NASDAQ Listed Jun 25, 2021$5.24
+5.86%
vs $4.95
Mkt Cap $280.3M
52w Low $1.99
74.2% of range
52w High $6.37
50d MA $3.87
200d MA $3.94
P/E (TTM)
—
EV/EBITDA
—
P/B
4.1x
Debt/Equity
0.2x
ROE
-25.1%
P/FCF
-30.4x
RSI (14)
47.50
ATR (14)
$0.49
Beta
0.33
50d MA
$3.87
200d MA
$3.94
Avg Volume
188.6K
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
CIK (SEC)
Phone
831 637 1100
2290 Bert Drive · Hollister, CA 95023 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | -0.09 | -0.08 | +13.6% | 3.64 | +1.9% | +9.9% | -4.2% | -0.5% | +4.7% | -2.0% | — |
| Feb 26, 2026 | AMC | -0.09 | -0.09 | +0.0% | 2.28 | +0.0% | +13.2% | -7.8% | -1.7% | +0.0% | -5.6% | — |
| Nov 6, 2025 | AMC | -0.09 | -0.08 | +14.7% | 4.81 | -6.2% | -2.1% | -2.1% | +6.3% | -9.0% | -0.7% | — |
| Aug 7, 2025 | AMC | -0.10 | -0.07 | +30.3% | 4.34 | +26.3% | -2.5% | +4.3% | +8.4% | +2.1% | -1.6% | — |
| May 8, 2025 | AMC | -0.11 | -0.09 | +18.2% | 6.37 | +14.6% | +9.3% | +1.4% | -4.5% | -3.3% | -0.2% | — |
| Mar 4, 2025 | AMC | -0.12 | -0.11 | +8.3% | 6.04 | +9.6% | -1.2% | -4.0% | +6.3% | -9.4% | -2.5% | — |
| Nov 7, 2024 | AMC | -0.11 | -0.15 | -36.4% | 6.89 | +8.7% | +3.9% | +5.6% | -15.6% | -2.0% | +5.0% | — |
| Aug 13, 2024 | AMC | -0.16 | -0.13 | +18.8% | 3.97 | +1.8% | -6.5% | +8.4% | +23.1% | -1.6% | +1.4% | — |
| May 13, 2024 | AMC | -0.24 | -0.20 | +16.7% | 1.74 | +4.0% | +12.1% | -3.6% | +1.1% | -5.8% | +0.0% | — |
| Mar 11, 2024 | AMC | -0.23 | -0.22 | +4.3% | 3.02 | -5.3% | -5.6% | +0.4% | +3.8% | -4.0% | +0.0% | — |
| Nov 9, 2023 | AMC | -0.28 | -0.34 | -21.4% | 2.01 | -1.5% | -3.0% | +4.1% | +3.0% | +2.4% | -3.3% | — |
| Aug 10, 2023 | AMC | -0.26 | -0.25 | +3.8% | 2.80 | -4.6% | +2.1% | -7.0% | +4.5% | +1.1% | -7.5% | — |
| May 10, 2023 | AMC | -0.30 | -0.31 | -3.3% | 1.94 | -0.5% | -3.6% | +4.8% | +0.5% | +1.0% | +6.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10 | Stephens & Co. | Maintains | Overweight → Overweight | — | $1.23 | $1.25 | +1.6% | -0.8% | +1.6% | +3.2% | +0.0% | +5.5% |
| May 14 | Stephens & Co. | Maintains | Overweight → Overweight | — | $1.74 | $1.81 | +4.0% | +12.1% | -3.6% | +1.1% | -5.8% | +0.0% |
| Mar 12 | BTIG | Downgrade | Buy → Neutral | — | $3.02 | $2.86 | -5.3% | -5.6% | +0.4% | +3.8% | -4.0% | +0.0% |
| Aug 11 | Stephens & Co. | Maintains | Overweight → Overweight | — | $5.79 | $5.53 | -4.5% | -19.3% | +7.3% | +3.3% | +4.9% | -11.2% |
| Mar 16 | Stephens & Co. | Maintains | Overweight → Overweight | — | $14.84 | $14.61 | -1.5% | +1.1% | -4.9% | +18.8% | -13.6% | -0.1% |
| Jul 20 | BTIG | Maintains | Buy → Buy | — | $18.06 | $18.99 | +5.1% | -2.5% | +0.9% | +1.0% | -0.2% | -2.4% |
| Jul 20 | Stephens & Co. | Maintains | Overweight → Overweight | — | $18.06 | $18.99 | +5.1% | -2.5% | +0.9% | +1.0% | -0.2% | -2.4% |
| Jul 20 | TD Cowen | Maintains | Outperform → Outperform | — | $18.06 | $18.99 | +5.1% | -2.5% | +0.9% | +1.0% | -0.2% | -2.4% |
No insider trades available.
8-K · 5.02
!!! Very High
Alpha Teknova, Inc. -- 8-K 5.02: Executive Change
Alpha Teknova appoints Ms. Demski as director effective June 1, 2026, bringing new leadership perspective to the board.
Jun 1
8-K · 2.02
!! High
Alpha Teknova, Inc. -- 8-K 2.02: Earnings Results
Alpha Teknova reported earnings results showing changes in operations and financial condition, with details available in the attached press release for investor evaluation.
May 6
8-K
Alpha Teknova, Inc. -- 8-K Filing
Alpha Teknova reported 2025 revenue of $40.5 million, up 7% year-over-year, and guided 2026 revenue to $42-44 million, indicating modest continued growth expectations.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Roubaix Capital, Llc | 1,882,355 | $5M | Added | Mar 2026 |
| 2 | Millennium Management | 447,138 | $1M | New | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 441,879 | $1M | New | Mar 2026 |
| 4 | Ubs Group Ag | 325,163 | $940K | Reduced | Mar 2026 |
| 5 | Conestoga Capital Advisors, Llc | 317,084 | $916K | — | Mar 2026 |
| 6 | Bank Of America Corp /de/ | 228,286 | $660K | Added | Mar 2026 |
| 7 | Morgan Stanley | 151,334 | $575K | Reduced | Dec 2025 |
| 8 | Bank Of New York Mellon Corp | 99,969 | $289K | Reduced | Mar 2026 |
| 9 | Northern Trust Corp | 95,978 | $277K | Added | Mar 2026 |
| 10 | Jane Street Group, Llc | 62,903 | $239K | New | Dec 2025 |
| 11 | Divisadero Street Capital Management, Lp | 78,872 | $228K | — | Mar 2026 |
| 12 | Mount Lucas Management Lp | 70,000 | $202K | — | Mar 2026 |
| 13 | Aqr Capital Management Llc | 66,405 | $192K | New | Mar 2026 |
| 14 | Vanguard Portfolio Management Llc | 64,511 | $186K | New | Mar 2026 |
| 15 | Citadel Advisors Llc | 60,381 | $175K | Reduced | Mar 2026 |
| 16 | Marshall Wace, Llp | 45,167 | $131K | Reduced | Mar 2026 |
| 17 | Two Sigma Investments, Lp | 19,117 | $55K | Reduced | Mar 2026 |
| 18 | R Squared Ltd | 14,376 | $42K | New | Mar 2026 |
| 19 | Nuveen, Llc | 14,158 | $41K | — | Mar 2026 |
| 20 | Vanguard Personalized Indexing Management, Llc | 12,081 | $35K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$280.3M
Enterprise Value
$287.6M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.27x
P/B
4.08x
P/S
6.70x
P/FCF
-30.36x
EV/EBITDA
—
Shares Out
53.5M
Financials (TTM)
Revenue
$41.8M
Net Income
-$17.2M
EBITDA
-$10.0M
Free Cash Flow
-$9.2M
Op Cash Flow
-$8.6M
EPS Basic
$-0.32
EPS Diluted
$-0.32
EPS Forward
$-0.35
Gross Margin
33.3%
Op Margin
-39.0%
Net Margin
-41.1%
Balance Sheet
Total Assets
$103.6M
Total Liab.
$34.8M
Total Equity
$68.8M
Cash
$5.9M
LT Debt
$13.3M
Book Value/Sh
$1.29
Debt/Equity
0.22x
Current Ratio
4.58
Quick Ratio
3.64
Returns & Growth
ROE
-25.1%
ROA
-16.7%
ROIC
-17.3%
Rev Growth YoY
+7.3%
EPS Growth YoY
+43.9%
Price Returns
2W
+45.2%
1M
+52.1%
3M
+109.3%
6M
+15.4%
12M
-6.4%
Technicals
52W High
$6.37
52W Low
$1.99
50d MA
$3.87
200d MA
$3.94
RSI (14)
47.50
ATR (14)
$0.49
Beta
0.33
Avg Volume
189K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 27, 2026 4:54am
· Source: financialmodelingprep.com